Coronavirus | Antibodies cocktail treatment results encouraging, says BMC

It has reduced treatment period from 13 to 14 days to 5 to 6 days and only one out of around 200 patients required oxygen supply, it claims

The treatment of COVID-19 patients with mild to moderate symptoms with an antibodies’ cocktail of Casirivimab and Imdevimab has reduced the treatment period from 13 to 14 days to 5 to 6 days and only one out of around 200 patients required oxygen supply, said the Brihanmumbai Municipal Corporation (BMC) on Monday. The civic body treated 200 patients with the cocktail at the Seven Hills hospital in Andheri, and according to officials, the results were encouraging. The BMC said that only one (0.5%) patient required oxygen supply after this line of treatment and the death rate came down by 70%.